ReShape Lifesciences Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ReShape Lifesciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
  • ReShape Lifesciences Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $32K, a 85.2% decline year-over-year.
  • ReShape Lifesciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $281K, a 68.6% decline year-over-year.
  • ReShape Lifesciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $767K, a 63.2% decline from 2022.
  • ReShape Lifesciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.09M, a 82.9% decline from 2021.
  • ReShape Lifesciences Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.2M, a 824% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $281K $32K -$184K -85.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $465K $65K -$152K -70% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $617K $72K -$150K -67.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $767K $112K -$127K -53.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $894K $216K -$143K -39.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $1.04M $217K -$553K -71.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $1.59M $222K -$497K -69.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $2.09M $239K -$1.53M -86.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $3.62M $359K -$10.4M -96.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $14M $770K +$1.13M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $12.8M $719K +$618K +612% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $12.2M $1.77M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $10.7M +$10.5M +4104% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$364K -$711K -205% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-19
Q1 2021 $101K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q3 2020 $255K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $347K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.